Drug recall · March 1, 2017
CycloSPORINE Capsules recall
Why: Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, Manufactured for Apotex Corp., Weston, FL --- NDC 60505-0134-0
- Lots / codes
Lot MJ9837, Exp 07/2017. NDC 60505-0134-0, UPC 360505013401
- Quantity
- 19,584 bottles
- Company
- Apotex Inc., North York, N/A
- Distribution
- Distributed Nationwide
- Initiated
- February 3, 2017 · Voluntary: Firm initiated
- Classified
- February 23, 2017
- Reported
- March 1, 2017
- Ended
- June 15, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyclosporine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.